BPC-157 has a real, unusually stable structure and a genuinely striking animal-trial record — and almost no controlled human data, an FDA compounding ban, and a supply chain that self-injects with no regulatory floor under it. Here's what the evidence actually supports.
Regulation
-
BPC-157 and the Research-Peptide Gray Market -
Melanotan and the Peptide Underground The same 1980s skin-cancer-prevention research that produced an FDA-approved drug for a rare light-sensitivity disorder also produced melanotan II — a gray-market tanning peptide whose non-selective receptor binding causes the appetite and libido effects users chase and the mole changes, priapism, and cardiac events regulators warn about.
-
Right to Repair Honestly: The 2026 State of Play Right to repair is not a contract fight, it is an architecture fight. Manufacturers design repair out at the silicon and protocol level — parts pairing, telematics lockout, signed firmware — and the law is only now catching up. Here is the honest 2026 picture across cars, tractors, and phones, the mechanisms underneath the politics, and what owners actually get.